An update on semaglutide for CKD in the presence of T2D

Description

In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Jane Elliott AM & Prof Rod Baber AM

Dr Jane Elliott AM & Prof Rod Baber AM

Non-Hormonal Options for Menopausal Symptoms

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Holter Monitoring in GP – Cases and Practical Tips

Dr Rupert Hinds

Dr Rupert Hinds

Management of Constipation in Children

A/Prof Greg Katsoulotos

A/Prof Greg Katsoulotos

Inhaler Devices – Common User Errors

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Richard MacIsaac

expert

Prof Richard MacIsaac

Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne

Date published: 30 March 2026